Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $574.0500 (5.87%) ($574.0500 - $574.0500) on Tue. May. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.81% (three month average) | RSI | 66 | Latest Price | $574.0500(5.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.7% a day on average for past five trading days. | Weekly Trend | REGN declines -1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) IVW(36%) SPLV(36%) IWF(35%) | Factors Impacting REGN price | REGN will decline at least -1.905% in a week (0% probabilities). VIXM(-19%) VXX(-7%) UUP(-6%) TBT(-6%) IYT(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.905% (StdDev 3.81%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $536.53(6.99%) | 10 Day Moving Average | $544.42(5.44%) | 20 Day Moving Average | $538.11(6.68%) | To recent high | 0% | To recent low | 54% | Market Cap | $60.866b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |